The future of cancer diagnostics

What we do

At LIQOMICS we strive to improve cancer treatment. Requiring only a blood sample, we use circulating tumor DNA to understand the genetics of an individual cancer and monitor treatment with razor-sharp sensitivity.

Who we are

LIQOMICS is an academic spin-off company founded in 2021 in Cologne, Germany. We aspire to bring our cutting-edge liquid biopsy technology from the lab to patients worldwide.


© LIQOMICS GmbH 2021